The Physiology of Immune Therapies and Their Application in Treating Gastrointestinal Cancers

The advent of immune therapies has ushered in a new and exciting era in cancer treatment. Immune therapy alone or combined with established regimens, including chemotherapy and radiotherapy, has been successfully used for the treatment of melanoma and blood cancers. These treatments are increasingly being adapted for previously refractive solid cancers, including those of the gastrointestinal tract. This Call for Papers focuses on the mechanisms of action and application of checkpoint inhibition, adoptive immunotherapy (CAR-T cells), and cytokine therapy, both selectively or combined with other treatment regimens, in the treatment of established gastrointestinal cancers from esophagus to rectum.

All manuscripts should be submitted online via eJournalPress.. During the online submission process, under the “Classifications" folder, please use the “Category” drop-down menu and select “Call for Papers: Translational Human Physiology and Pathophysiology.”

Manuscripts will undergo normal peer review as they are received. Accepted manuscripts will be published online as they are accepted. Articles published from this Call for Papers will be highlighted at the time of publication. The collection may also include specially commissioned review or research articles related to the topic.

Manuscripts can be submitted anytime, but to be eligible for inclusion in this Call for Papers, manuscripts must be submitted by April 30, 2019.